Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used to treat diabetes and for weight loss, may be linked with a reduced risk of substance use and neurocognitive disorders, a US study in people ...
Surgery is the gold standard, GLP-1s are all the rage—whether a head-to-head study is needed depends on who you ask.
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...
People lose weight via three primary methods: diet and exercise, weight loss surgery and GLP-1 weight loss drugs. The suggested method is based on the amount of weight a person wants or needs to ...
GLP-1s, the popular medications helping millions of people lose weight by curbing their appetites ... Another report from Circana found that GLP-1 users traditionally spent more at c-stores ...
Popular GLP-1 medications approved for weight loss, diabetes ... as well as how they compare to treatments that are already available. There’s at least one study underway to try to answer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback